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Highly Mutable Linker Regions 
Regulate HIV-1 Rev Function and 
stability
Bhargavi Jayaraman1, Jason D. Fernandes1,3, shumin Yang1,2, Cynthia smith1 & 
Alan D. Frankel1
HIV-1 Rev is an essential viral regulatory protein that facilitates the nuclear export of intron-containing 
viral mRNAs. It is organized into structured, functionally well-characterized motifs joined by less 
understood linker regions. Our recent competitive deep mutational scanning study confirmed many 
known constraints in Rev’s established motifs, but also identified positions of mutational plasticity, 
most notably in surrounding linker regions. Here, we probe the mutational limits of these linkers by 
testing the activities of multiple truncation and mass substitution mutations. We find that these regions 
possess previously unknown structural, functional or regulatory roles, not apparent from systematic 
point mutational approaches. Specifically, the N- and C-termini of Rev contribute to protein stability; 
mutations in a turn that connects the two main helices of Rev have different effects in different 
contexts; and a linker region which connects the second helix of Rev to its nuclear export sequence has 
structural requirements for function. Thus, Rev function extends beyond its characterized motifs, and 
is tuned by determinants within seemingly plastic portions of its sequence. Additionally, Rev’s ability 
to tolerate many of these massive truncations and substitutions illustrates the overall mutational and 
functional robustness inherent in this viral protein.
Proteins balance optimal functionality with mutational tolerance in order to adapt to changes in selection pres-
sures1. Proteins with high tolerance for mutation are considered genetically “robust” or “plastic”, while proteins 
with a low mutability are considered genetically “fragile” or “brittle”2. The existence of a protein sequence as frag-
ile or robust is a result of evolutionary pressures acting on the protein, such as mutation rate and biological func-
tion. Fragility and robustness are generally expected to couple with protein structure and disorder: disordered 
regions are expected to be robust while structured regions are comparatively brittle3,4.
Viral proteins maintain their function amidst many forces such as high viral polymerase error rates, immune 
pressures, and even competing selective pressures from overlapping reading frames and RNA structures. HIV-1 
Rev is one such essential viral protein which facilitates the nuclear export of intron-containing viral RNAs that 
encode essential viral structural and enzymatic proteins and provide full length genomes for encapsidation5–7. 
Rev experiences a high mutation rate in HIV (~10−3 mutations per base per cell8) and is also overlapped with two 
other essential viral proteins, Tat and Env (Fig. 1A). Overlap between viral genes is common9, but most HIV-1 
genes have at least one region with no overlap in which they can encode critical functional domains in an uncon-
strained way (as we recently observed with HIV-1 tat10). In contrast, rev shares coding information with other 
viral genes throughout its length (the only HIV-1 gene encoded in such a manner) meaning that its evolution is 
coupled to these overlapping genes.
Because of the overlap, the true functional importance of each Rev residue is difficult to assess from traditional 
sequence conservation analyses and instead requires careful mutational dissection in non-overlapped contexts. 
To address this, we recently performed competitive deep mutational scanning (CDMS) in non-overlapped viral 
replication assays10. These experiments allowed us to examine for the first time, the amino acid preferences/fitness 
in Rev at each position, when unconstrained by overlapping genes.
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Results from these experiments showed that, in general, the known structured/functional regions of Rev 
experience selective pressure for specific side chains while the linker regions between/flanking these structured 
domains appear to be relatively “plastic”, freely mutating between many different side chains with a variety of 
chemical properties (Fig. 1B,C). However, the true extent of this plasticity is unclear, as the approach only exam-
ined single point mutations within a reference viral strain background.
In this study, we expand our analyses of the point mutational datasets to evaluate the limits of the structural 
and mutational plasticity of Rev’s structured domains and unstructured linker regions by designing deletion 
and mass substitution mutations and testing them for function in reporter assays and viral replication assays. 
Our results indicate that most of the linker regions possess previously unappreciated structural, functional or 
regulatory roles, not apparent from systematic point mutational approaches, while the structured regions tolerate 
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Figure 1. Structure and Organization of HIV-1 Rev. (A) Domain organization of Rev protein (NL4-3/HXB2 
numbering) with interaction surfaces in shades of red (OD: Oligomerization domain; ARM: Arginine-Rich 
Motif; NES: Nuclear Export Sequence) and linker regions in grey (N-term: N-terminus, Turn, ONL: OD-NES 
Linker). In the viral genome, the Rev coding sequence consists of two exons (Fig. 1A; “splice site” denotes 
exon-exon junction as it would occur in the mRNA) both of which are contained entirely within (alternative 
reading frame) exons of two other HIV genes, Tat and Env. Putative structured domains of Tat (ARM: Arginine 
Rich Motif) and Env (LLP: Lentivirus lytic peptide) are shown along with their overlap with Rev domains. 
(B) Structural model of Rev built using Rev crystal structures (residues 8–62 from PDBID: 3LPH; residues 
76–83 from PDBID: 3NBZ; all other regions were built in PyMOL for visualization purposes). Also shown 
is the experimental fitness of every residue in the Rev linker regions (from10) (C). Distribution of median 
experimental fitness values of each residue for different regions of Rev classified by domain organization (data 
from10). Specifically, there are 116 total data points each representing a single residue of Rev, each binned into 
the appropriate domain; the representative value for each residue is the median fitness of all 21 side chains (and 
the stop codon) at that position).
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more variation than expected. The N- and C-termini control Rev stability; mutations in a turn that connects the 
two main helices of Rev have different effects in nuclear export assays and viral replication assays, suggesting an 
alternate functional role besides nuclear export for this region; and a linker region connecting the second helix 
of Rev to its nuclear export sequence becomes structured at some point in Rev’s export function. Overall, our 
study illustrates for the first time how these linker regions are closely involved in Rev function either by direct 
functional roles or by more subtle regulatory roles. In sum, these experiments make evident Rev’s extraordinary 
genetic robustness, which is achieved via the use of malleable macromolecular interaction surfaces spaced by 
even more malleable linker regions that can more finely tune those interactions.
Results
Competitive deep mutational scanning (CDMS) data recapitulates Rev domain structure. Rev 
plays an essential role in the viral life cycle, coordinating the nuclear export of unspliced or partially spliced 
mRNAs for translation of key viral proteins or encapsidation of full-length viral genomes. Rev recognizes a ~350-
nt structured RNA within the intron known as the Rev Response Element (RRE) using an arginine-rich motif 
(ARM) for binding, and forms an oligomeric assembly on the RRE using two hydrophobic oligomerization motifs 
or domains (ODs)11,12. This Rev-RRE complex then recruits the host nuclear export factor Crm1, using a nuclear 
export sequence (NES) in Rev, together with RanGTP to transport these RNAs to the cytoplasm and thereby 
circumvent splicing5,6.
The three main functional regions of Rev (ARM, OD, and NES) are flanked by linker regions13–17 (Fig. 1A,B). 
The structure of the OD is formed by the interaction of two OD helices, where the second helix extends beyond 
the 15 residues of the helical ARM15. The NES forms its structure upon binding to Crm118. The regions that flank 
these functional domains include: a short N-terminal tail (N-term), a proline-rich turn between the first and sec-
ond helices (turn), a linker between the second helix and the NES (OD-NES Linker: ONL) and a long, disordered 
C-terminal tail (C-term)6,19 (Fig. 1B).
We utilized the fitness values for every possible Rev allele derived from a competitive deep mutational scan-
ning (CDMS) dataset, where Rev was engineered into non-overlapped viruses and all substitutions at individual 
positions were competitively replicated, to deduce functional signatures of amino acid selection10. These data are 
consistent with our current biochemical and structural understanding of Rev, as we observe that the structured 
regions display low mutational tolerance (low median fitness in these regions indicates that only a few side chains 
are fit at each position) whereas the linker regions display high mutational tolerance (near-neutral median fit-
ness indicates that almost all side chains are fit) (Fig. 1B,C). The mutational plasticity of the linker regions is also 
apparent in the heat maps of all individual point mutations, further corroborating the underlying structural and 
functional boundaries (Fig. 1B).
The Rev OD is highly plastic at the sequence and structural levels. We first examined the amino 
acid requirements of the OD in more detail. Rev function requires binding of a homo-oligomer of 6–10 subunits 
to the RRE11,12,19–22. The OD is comprised of two helices which contain hydrophobic residues necessary both for 
oligomerization and for interacting with host proteins, such as hnRNPs and RNA helicases23–26. The OD forms 
three hydrophobic surfaces with some residues shared between the surfaces: 1) a monomer stabilization interface 
in which side chains from each helix of the OD (residues 19, 22, 52 and 59) stabilize the monomer structure of 
Rev, 2) a dimer interface which supports formation of a Rev dimer upon nucleation of Rev assembly on the RRE 
(residues 18, 22, 55 and 59 and residue 21 in one dimer configuration), and 3) a higher-order interface oppo-
site the dimer interface which allows the formation of the larger Rev oligomer (residues 12, 16 and 60)13,14,27,28 
(Fig. 2A).
One very provocative feature of the Rev OD is that variation in the packing of its hydrophobic residues leads 
to multiple configurations of Rev dimers and oligomers15,29,30. This structural plasticity underlies the ability of 
Rev to assemble into an oligomeric complex on the RRE and raises the question of how constrained these side 
chains must be. CDMS data10 show that interaction residues in each interface display a general preference for 
hydrophobicity and size with occasional preference for aliphatic side chains over aromatic ones (Fig. 2B). For 
instance, in the dimer interface, residues 22, 55, and 59 prefer large aliphatic side chains while aromatic substitu-
tions are equally as fit as aliphatic ones at residue 19. Similar patterns are seen in the higher-order oligomerization 
interface with residues 12 and 60 accepting any large hydrophobic, residues 16, 55 and 60 having distinct prefer-
ences for aliphatic residues. Interestingly, residue 23, although not part of currently known oligomeric interface 
configurations, strongly prefers F or Y (Fig. 2B). In summary, this ability of the OD to make functionally neutral 
mutations between chemically similar side chains (e.g. I, L & V and in some cases W, F, and Y) at such functional 
critical positions increases the mutational robustness and prevents the “brittleness” that essential interfaces in 
other proteins can possess.
The Rev NES and ARM balance fragility and plasticity. The Rev ARM serves as both the RRE-binding 
domain as well as a nuclear localization signal (NLS) through interactions with Importin-β31. It can recognize 
diverse RNA sites depending on the RNA structure and the orientation/placement of ARM residues15,20,32. 
Additionally, residues in the ARM also enhance the monomer core structure through hydrogen bonds13. Given 
these numerous functional constraints, most residues of the ARM, including the non-basic residues Q36 and 
W45, show strong selection in the CDMS study (Fig. 3A). Another residue, Q51, implicated in stabilizing an 
RNA-bound Rev dimer through hydrogen bonds15 also shows strong selection, reaffirming its importance in 
Rev-RRE assembly.
The Rev NES recruits Crm1 to the Rev-RRE RNP, and recent EM studies show that a Crm1 dimer is associ-
ated with the RNP33. Structural studies of a Rev NES peptide bound to Crm1 have shown that Rev binds Crm1 
in a non-canonical manner (Fig. 3B), using prolines to properly space hydrophobic residues to contact Crm1. 
4Scientific RepoRts |          (2019) 9:5139  | https://doi.org/10.1038/s41598-019-41582-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
Curiously, CDMS data shows that P76, which contacts the Crm1 binding groove, is as fit as a hydrophobic residue 
(L, I), whereas L75 prefers to be a proline (Fig. 3C). Furthermore, like the OD, the hydrophobic residues in the 
NES that contact Crm1 are tolerant of most large aliphatic side chains (Fig. 3C,D).
In order to further evaluate the effect of Rev mutations within both the structured domains and linkers, we 
conducted a series of RNA export reporter assays together with replication assays of non-overlapped mutant 
viruses to avoid the confounding effects of overlapping reading frames (Fig. S1)10. The reporter assay monitors 
Rev-dependent p24 capsid expression from a CMV promoter-driven truncated viral genome in 293 T cells34,35 
and the replication assay utilizes rev-in-nef viruses as previously described10. The combination of assays also 
allows us to potentially uncover additional functions of Rev in the replication context.
We tested both Rev L75P and P76L mutants for function in our reporter assay and observed only 60% activity 
(Fig. 3E), while the corresponding viral spreads were comparable to wild-type Rev, consistent with the CDMS 
data (Fig. 3F). These observations strongly indicate that Rev is able to tolerate greater variability to mutation of 
Crm1 binding residues than expected and that the loss of activity observed in our reporter assay is still above 
some functional minimum, or that other mechanisms, present in the context of viral replication, compensate for 
this loss of activity.
The OD, ARM and NES are all structured, critical regions of Rev, where a point mutation is often suffi-
cient to abolish function. While our CDMS data indicate that many residues of the OD and NES are tolerant to 
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substitutions, conferring mutational robustness/plasticity, the ARM has more stringent sequence preferences. 
This may reflect the more complex nature of interactions mediated by the ARM (polar, charged, directional as 
well as RNA and protein), making it relatively more fragile than the OD or NES.
The N- and C-termini influence Rev stability. While the function of the ARM, OD and NES are fairly 
well understood, the roles of the linkers in Rev function, apart from connecting the modules, is less clear. Since 
most residues within these regions do not experience strong selection for a specific amino acid/category, point 
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mutational datasets are insufficient to determine their sequence constraints. Thus, we constructed a series of 
truncation and gross substitution mutations within these regions and measured their activities to interrogate their 
functions more rigorously.
The N-terminal 8 residues of Rev are disordered in most crystal structures (Fig. 1B)13–15,29, but a recent struc-
ture of a scFv-bound Rev solved at 2.3 Å shows that the first helix begins at residue 5 (PDB ID: 5DHV)29. Genetic 
screens and selection assays have identified residue 12 as the first essential contact in the Rev OD27,28. The pres-
ence of an overlapping reading frame encoding the critical ARM of Tat, another essential viral protein, has con-
founded conservation analyses of the Rev N-terminus. Indeed, previous work suggests that this region does not 
experience strong selective pressure (excluding requirements for translation initiation), but is well conserved in 
Rev in order to maintain Tat function10.
To more fully investigate the role of N-terminus of Rev, we measured the effects of truncations in our export 
assay. Deleting the first 10 residues (Rev ∆1–10) had no effect on activity whereas any further truncation resulted 
in loss of activity (Fig. 4A). Replication spreads of viruses containing these truncations recapitulated the export 
results, with the virus expressing Rev ∆1–10 replicating similar to the wild-type Rev virus, whereas the Rev 
∆1–11 virus failed to replicate (Fig. 4B). These results corroborate that the first 10 residues of Rev are not required 
for function.
Unexpectedly, none of the truncated Rev proteins could be detected by western blot, despite some (such as 
Rev ∆1–10) being functional in both reporter and replication assays (Fig. 4A,B). Previous reports have shown 
that Rev function is robust even at very low expression levels36,37. Indeed, we observed that serial dilutions of 
Rev plasmid demonstrated high reporter activity at even very low levels and that activity was actually reduced at 
higher plasmid levels (Fig. S2A). Therefore, we inferred that the truncated Rev proteins were being expressed at 
levels sufficient for function but below the level of detection. There was no significant change in the stability of 
truncated-Rev expressing mRNA (Fig. S2B) indicating that the truncation affects only protein stability. We were 
able to detect low levels of truncated Rev in the presence of proteasome inhibitor, MG132 (Fig. 4C), suggesting 
that the truncated proteins were being degraded by the proteasome. We next made smaller truncations to deter-
mine at which point Rev expression was restored and found that Rev ∆1–8 showed modest expression whereas 
Rev ∆1–5 showed near-wild-type expression. The results suggest that the truncations affect the ability of the first 
helix to form completely and stably (Fig. 4D), thereby influencing protein stability. Remarkably, early mutational 
work on Rev also identified point mutations in the N-terminus (R4S5 to D4L5) that reduced Rev stability without 
completely abolishing function38.
We also monitored Rev expression from NL4–3 viruses in infected T-cells, a more relevant condition. We 
utilized Rev with a C-terminal Flag tag (for ease of detection) in rev-in-nef viruses15, infected SupT1 cells with 
these viruses and tracked Rev expression in cell lysates. Rev ∆1–8 displayed poorer expression than full-length 
Rev, confirming the reduced stability of Rev in T-cells (Fig. 4E), yet conferred no defect in replication. Overall, 
our findings indicate that the N-terminal residues are not required for replication but nevertheless contribute to 
Rev stability.
The Rev C-terminus (residues 70–116) is disordered in crystal structures although recent work has suggested 
that it may become ordered in certain contexts. Cryo-EM studies have suggested that residues 94–116 become 
ordered when Rev forms filaments29, and C-terminal truncations (1–69 and 1–93) do not form filaments under 
the same conditions. Evolutionary coupling analysis also suggests that the C-terminus can engage in long-range 
contacts and become structured39. Early truncation studies on Rev at various positions beyond the nuclear export 
sequence indicated that truncated Rev was functional38,40–42. CDMS data show that selection against stop codons 
ends at residue 86 (the NES ends at residue 83) (Fig. 5A) indicating that the C-terminus is not required for viral 
replication. Curiously, the distribution of fitness values for stop codons between position 86–116 is overall pos-
itive (Fig. 5B; red distribution is right shifted), indicating that viruses with a truncated Rev might have a com-
petitive advantage compared to wild-type virus and suggesting an inhibitory role for the Rev C-terminus39. This 
distribution is distinct from that of the C-terminus of Tat, another overlapped essential HIV protein, where the 
fitness values of stop codons appear to be near neutral after the last functional Tat domain at residue 65 (Fig. 5B; 
blue distribution centered around zero).
C-terminal truncations (Rev 1–85, Rev 1–83) are functional in our reporter and replication assays, further 
confirming that this region is dispensable for function, while truncation of a single residue in the NES (Rev 1–82) 
results in a dramatic loss of function (Fig. 5C,D). Similar to the N-terminal truncations, we were unable to detect 
Rev protein with C-terminal truncations despite functional reporter activity, with no significant change in the sta-
bility of truncated-Rev mRNA (Fig. S2B), and observed low levels of truncated Rev in the presence of proteasome 
inhibitor, MG132 (Fig. 5E). However, unlike the N-terminus, smaller truncations did not restore Rev expression 
as 1–85, 1–90 and 1–100 all express poorly (Fig. 5F). Intriguingly, previous studies of C-terminal truncations in 
COS cells did not result in reduced protein stability38. Rev 1–85 also displayed reduced stability in virus-infected 
T-cells, although the virus replicates as well as the wild-type Rev virus (Fig. 5G). Thus, the C-terminus, like the 
N-terminus, is not required for RNA export or viral replication but regulates protein stability in a manner whose 
mechanism and functional consequence are not yet understood.
Substitutions to the Rev turn produce different effects on RNA export and viral replication. 
Rev contains an 8-residue proline rich turn which separates the first two helices and spans the exon junction 
in the viral genome (Fig. 1A,C). Recent structural studies implicate the turn residues as part of an additional 
Rev-Rev interaction surface where residues W45, P28, P29 and P31 “hook” with the same residues on an adjacent 
Rev molecule. This interface has been proposed to act as a molecular bridge between independent oligomeri-
zation events along the RRE29,30. Most residues in the turn do not have strong preferences in the CDMS study 
(Fig. 1B)10, consistent with our understanding of the region as a simple linker. However, residue 28 demonstrated 
a strong preference for an aromatic side chain (W,F,Y) rather than the reference NL4–3 proline (P) (Fig. S3). 
7Scientific RepoRts |          (2019) 9:5139  | https://doi.org/10.1038/s41598-019-41582-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
Interestingly, the most common allele in patient sequences is Y28, although P28 is also substantially represented 
and is found in many lab-adapted HIV-1 strains43. It is possible that a P28Y substitution could provide stacking 
interactions to stabilize this aromatic interface within the turn30, but we found no significant difference in activity 
between the proline and tyrosine variants (Fig. S3). Even an alanine substitution at position 28 is only marginally 
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Figure 4. The HIV-1 Rev N-terminus is not required for function but regulates Rev stability. (A) Reporter assay 
probing export activity of Rev N-terminal truncations. Data are mean ± standard deviation (s.d) of biological 
replicates. Western blots below show protein expression for Strep-tagged Rev and GAPDH as loading control. 
(B) Viral replication profiles of viruses containing Rev with N-terminal truncations. Data are mean ± s.d of 
biological triplicates. Viral p24 levels below 1000 pg/ml are shown as 1000 pg/ml in the plots for illustration 
purposes. (C) Adding MG132, a proteasome inhibitor partially restores expression of N-terminally truncated 
Rev in transiently transfected 293 T cells. Numbers above blots represent quantified band intensities for Rev 
mutants relative to WT-Rev. (D) Shortening the length of N-terminal truncations restores protein expression 
transiently transfected 293 T cells. Numbers above blots represent quantified band intensities for Rev mutants 
relative to WT-Rev. (E) N-terminal truncations affect Rev expression/stability from HIV-1 (with Flag-tagged 
Rev in the nef locus) in infected T-cells. Plot shows virus production from cell supernatant, quantified by p24 
ELISA. Western blots below show protein expression for Flag-tagged Rev and GAPDH loading control from the 
cells. The original blot for the cropped bands is shown in Fig. S5. Data are mean ± s.d of biological replicates.
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Figure 5. The HIV-1 Rev C-terminus is not required for function but regulates Rev stability. (A) Stop codon 
fitness distributions from CDMS dataset for Rev10. (B) Stop codon fitness distributions from CDMS dataset for 
Tat C-terminus (blue, residues 66–86) and Rev C-terminus (red, residues 86–116) (stop codon data for both 
proteins10. (C) Reporter assay probing export activity of Rev C-terminal truncations. Data are mean ± standard 
deviation (s.d) of biological replicates. Western blots below show protein expression for Strep-tagged Rev and 
GAPDH as loading control. (D) Corresponding viral replication spread experiments. Viral p24 levels below 
1000 pg/ml are shown as 1000 pg/ml in the plots for illustration purposes. Data are mean ± s.d of biological 
triplicates. (E) Adding MG132, a proteasome inhibitor partially restores expression of Rev with C-terminal 
truncations in transiently transfected 293 T cells. Numbers above blots represent quantified band intensities for 
Rev mutants relative to WT-Rev. (F) Shortening the length of C-terminal truncations does not restore protein 
expression transiently transfected 293 T cells. Here, we note that we consistently observe two bands for Rev 
1–90, one with a faster mobility and the second with the same mobility as full-length Rev. Numbers above blots 
represent quantified band intensities for Rev mutants relative to WT-Rev. (G) C-terminal truncations affect Rev 
expression/stability from HIV-1 (with Flag-tagged Rev in the nef locus) in infected T-cells. Plot shows virus 
production from cell supernatant, quantified by p24 ELISA. Western blots below show protein expression for 
Flag-tagged Rev and GAPDH loading control from the cells. The original blot for the cropped bands is shown in 
Fig. S5. Data are mean ± s.d of biological replicates.
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weaker in replication assays, indicating substantial sequence plasticity, but leaving the manner in which Y28 
confers a fitness advantage in competition experiments and in patients still unclear. Nevertheless, given that the 
turn appeared mutationally plastic in our CDMS studies and since it also determines the relative orientation of 
the first two helices, we examined its mutational limits with respect to side chain preference, length and structure.
To this end, we created a set of mutations that replaced the turn residues (26–33) with either all alanines 
(turn-8A, designed to promote helical propensity44) or glycines and serines (turn-8GS, designed to allow greater 
flexibility), and monitored the effects on Rev function in both reporter and replication assays. Surprisingly, we 
found that both variants yielded significant levels of export in the reporter assay (Fig. 6A) although neither was 
as active as wild-type Rev. However, shortening the length of the substitutions reduced export activity indicating 
that the turn must be of sufficient length to connect the two helices and produce functional Rev.
Despite significant activities in the reporter assay, all turn mutants were defective in replication, with only 
the turn-8GS mutant-virus showing any replication although severely attenuated (Fig. 6B). Given our previous 
observation that Rev is functional at even low concentrations, we repeated the reporter assay with 10-fold less 
Rev plasmid (2.5 ng versus 25 ng) to determine if less Rev expression might recapitulate the replication results. 
Indeed, the export activity of the turn-8A mutant dropped significantly at low Rev expression levels (Fig. 6C), 
indicating that it is defective and probably structurally unsuitable due to the replacement of a turn with a helical 
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Figure 6. The turn plays an intriguing role in Rev function (A) Reporter assay monitoring function of Rev 
constructs with mass substitution of turn residues 26–33. Data are mean ± standard deviation (s.d) of biological 
replicates. Western blots below show protein expression for Strep-tagged Rev and GAPDH as loading control. 
Numbers above blots represent quantified band intensities for Rev mutants relative to WT-Rev. The Turn-5A 
mutant shows reduced Rev expression suggesting that it might be less stable than the other mutants. (B) 
Corresponding viral replication spread experiments. Viral p24 levels below 1000 pg/ml are shown as 1000 pg/ml 
in the plots for illustration purposes. Data are mean ± s.d of biological triplicates. (C) Reporter assay monitoring 
export activity at 25 ng and 2.5 ng of transfected Rev plasmid. Western blots below showing protein expression 
for Strep-tagged Rev (at 2.5 ng only) and GAPDH as loading control. Data are mean ± standard deviation (s.d) 
of biological replicates and numbers above blots represent quantified band intensities for Rev mutants relative to 
WT-Rev. Export activity for both quantities of transfected Rev before normalization are shown in Fig. S3.
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region. These results are consistent with previous reporter assays showing loss of function when 27PPP29 was 
mutated to alanines45. However, the turn-8GS mutant remained active at the lower Rev plasmid level unlike the 
turn-8A mutant (Fig. 6B), despite wild-type Rev being 2-fold more active at the lower plasmid level (Fig. S2). This 
indicates that the turn need only provide flexibility between Rev helices in order for proper export although its 
export competence is not sufficient for viral replication.
The Rev OD-NES Linker (ONL) becomes structured. An ~11 residue linker region (ONL) connects 
the second helix of Rev and the NES and is disordered in most Rev crystal structures14,29. CDMS data suggests 
that the residues in this region can sample many amino acids with no clear preference for chemical property 
(Fig. 1C). In order to probe the requirements of length and structure for this region, we applied a strategy similar 
to that used to probe the turn. We replaced residues 62–72 of the ONL with either 11 alanines (ONL-11A, to 
mimic a rigid, structured linker) or 11 glycine-serines (ONL-11GS, to mimic a flexible disordered linker) and 
tested the effect of these substitutions in reporter and replication assays. ONL-11A was nearly fully functional in 
the reporter assay whereas ONL-11GS showed a marked decrease in activity (Fig. 7A). Viral replication spreads 
recapitulated this reporter data (Fig. 7B), with only the structured alanine linker displaying activity. In order to 
test the length requirements of this region, we shortened the ONL to nine (ONL-9A) or six (ONL-6A) alanines. 
ONL-9A displayed reduced function in the reporter assay but was surprisingly functional for replication, whereas 
ONL-6A was poor in both assays (Fig. 7A,B), demonstrating that the ONL has a minimum length requirement. 
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Figure 7. The OD-NES linker (ONL) needs to be structured for Rev function. (A) Reporter assay monitoring 
export function of Rev constructs with mass substitution of ONL residues 62–72. Data are mean ± standard 
deviation (s.d) of biological replicates. Western blots below showing protein expression for Strep-tagged Rev 
and GAPDH loading control and numbers above blots represent quantified band intensities for Rev mutants 
relative to WT-Rev. (B) Corresponding viral replication spread experiments. Viral p24 levels below 1000 pg/
ml are shown as 1000 pg/ml in the plots for illustration purposes. Data are mean ± s.d of biological triplicates. 
(C) Reporter assay monitoring export activity at 25 ng and 2.5 ng of transfected Rev plasmid. Western blots 
below showing protein expression for Strep-tagged Rev (at 2.5 ng only) and GAPDH as loading control. Data 
are mean ± standard deviation (s.d) of biological replicates. Numbers above blots represent quantified band 
intensities for Rev mutants relative to WT-Rev. Export activity for both quantities of transfected Rev before 
normalization are shown in Fig. S3.
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The activity levels of the ONL-9A and ONL-11A at reduced Rev expression levels (2.5 ng of Rev plasmid) were 
comparable to those obtained at 25 ng of Rev plasmid, demonstrating that this behavior holds for a broad range 
of Rev expression levels (Fig. 7C).
The ability of the ONL to tolerate complete replacement with alanines but not glycine/serine suggests that 
this region becomes structured during Rev function, possibly during oligomeric assembly on the RRE or Crm1 
binding. This finding is the first evidence that this region of Rev becomes structured during export; this behavior 
likely went undetected previously as prior approaches, such as our point mutational CDMS, typically examined 
the effect of individual point mutations, which alone appear insufficient to disrupt the induced structure.
Discussion
HIV Rev has been extensively investigated over three decades. Structural studies over the past several years 
have led to a model in which Rev is composed of a few highly conserved, structured regions with well-defined 
functions that are connected by disordered linkers (Fig. 1A). The results presented here expand the functional 
repertoire to these linker regions. Indeed, recent work in other systems has demonstrated the importance of dis-
ordered and linker regions for establishing and tuning protein interactions46–48, and particularly for modulating 
RNA-protein interactions49.
The use of disordered linkers to tune Rev function may reflect some of the selective pressures imposed by 
having its entire coding sequence overlapped with other HIV-1 genes, specifically tat and env (Fig. 1A). In pre-
vious work, we observed a complete segregation of function within the overlapped region of tat and rev, where 
the overlapped nucleotides encoded amino acids critical for the function of one protein or the other, but never 
both. Furthermore, the genetically fragile activation domain of Tat is encoded in a non-overlapped portion of 
the tat gene, consistent with the idea that brittle domains in which many mutations are expected to be lethal are 
unlikely to evolve within regions that must simultaneously maintain two overlapping coding sequences. Since Rev 
overlaps with other genes over its entire sequence, it apparently evolved relatively mutable interaction surfaces, 
such as the OD, to create genetic stability. The linker regions modulate Rev function and stability yet are even 
more mutable and as a result are effectively segregated at the coding level, imposing few constraints on the other 
reading frames.
Truncations of the N- and C-termini revealed that these regions greatly influence Rev protein stability, yet 
have little effect on Rev function in the context of our cellular reporter and replication assays. Proteomics studies 
have reported similar protein interaction profiles for N-terminal Rev truncations (∆1–8) and wild-type Rev25, 
indicating that N-terminus likely does not serve as a major interaction scaffold. However the N-terminus can be 
phosphorylated50, and may have regulatory effects that effect the function and/or stability of the protein in patient 
viral replication settings.
Intriguingly, the CDMS data suggest a fitness advantage to C-terminal truncations and thus a possible inhib-
itory role (Fig. 5A,B). A recent study proposed that the Rev NES can be masked in the cytoplasm, controlling 
Rev trafficking in and out of the nucleus36. We speculate that removing C-terminal residues might decrease the 
masking and thereby promote export of viral RNAs to provide a fitness advantage. Conversely, we observe that 
truncation of the C-terminus decreases protein stability, which might seem to negate any gains to export activity, 
however very little Rev is required for function, excessive amounts of Rev can lead to reduced export activity 
(Fig. S2), and viruses harboring undetectable amounts of Rev can replicate well (Figs 4E, 5G). Hence, it appears 
that truncating the C-terminus might increase fitness by reducing Rev levels to a more optimal level. However, 
we note that our viral replication experiments are performed with rev-in-nef, and nef transcripts are nearly 
two-fold more abundant than rev transcripts51,52. Therefore, some of the mutants with unaffected replication but 
reduced Rev stabilities might be compensated for via increased expression of Rev from the nef locus. Expression 
of truncated Rev from its endogenous locus might reveal the true limits for Rev expression and viral replication. 
However, the Rev C-terminus entirely overlaps with Env (Fig. 1A), and selection pressure from the Env reading 
frame (either functional requirements or immune targeting of specific Env epitopes) can influence Rev sequence 
and make stop codons unfavorable at most positions.
The Rev C-terminus length varies considerably amongst HIV-1 isolates (Fig. S4). Apart from the most com-
mon 116-amino acid form of Rev, some are 123 amino acids long due to a QSQGTET insertion between resi-
dues 95 and 96; other isolates carry this insertion as well as a premature stop codon and produce a truncated, 
107-amino acid Rev. Insertion of the QSQGTET sequence reduces export activity (Fig. S4), further suggesting 
that a long C-terminus inhibits spread, although further studies will be needed to reveal the exact mechanism and 
functional consequences of Rev C-terminus length.
Given Rev’s role in regulating HIV kinetics, multiple mechanisms might fine-tune Rev function within the 
context of replication. Indeed, the logic of gene expression networks involving Rev continues to be of major inter-
est to the HIV community, and has major implications for the mechanisms of HIV latency53–55. Our findings on 
Rev stability in a cell culture system therefore provide important parameters and considerations for future studies 
dedicated to deciphering viral kinetics and decoupling the selective pressures of Rev function from other selective 
pressures of viral replication in more complex systems.
The turn between the helices of Rev is highly mutable but does have certain requirements of length and flex-
ibility. The ability of the turn-8GS mutant to export well in the reporter assay yet fail to replicate suggests that 
this region may perform additional roles in viral replication. Alternately, the different results in different contexts 
could also be because of the cell types (and possibly, host factors for Rev interaction) used for reporter assays 
(293 T cells, transformed kidney cells) and viral replication assays (SupT1 cells, lymphoblastic T-cells). In any 
case, these results suggest that the turn may form an important functional interface. Recent structural studies 
have determined that the turn can form a homotypic interaction interface29,30, and mutations expected to stabilize 
this interface (P28Y) are enriched in both our CDMS data and patient data10. Further characterization will be 
required to determine the exact role of this interface and more generally the turn itself, in Rev function.
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Similarly, our manipulation of the ONL uncovered that it does not tolerate replacements that increase its 
propensity for disorder, suggesting that it becomes structured during some step of export complex formation. 
Since this stretch of residues can be replaced with alanines without significant loss of function, it appears that 
these residues do not form a specific interaction surface, but instead play a structural role, in which the specific 
sequence itself is unimportant as long as the region can adopt a presumably helical structure. Negative-stain elec-
tron microscopy has shown that a Crm1 dimer binds to the Rev-RRE complex with the two NES-binding grooves 
distinctly positioned to associate with two NESs from the complex33. A structured ONL might reduce the entropic 
penalty associated with Crm1 assembly and also fix NESs into a favorable orientation for this interaction, thereby 
improving the energetics of export complex formation.
To examine how a structured ONL might impact Rev-RRE-Crm1 complex formation, we re-visited previous 
models for Rev-RRE-Crm1 complex assembly15. Given the established plasticity in RRE structure and the hydro-
phobic Rev interaction surfaces, we proposed earlier that these features allow Rev-RRE complexes with varying 
sequences to adopt configurations favorable for Crm1 recruitment and nuclear export15. Adding the requirement 
that the OD-NES linker needs to be structured (helical with the limitations imposed by two prolines in the NL4–3 
sequence), we built a model of a Rev monomer containing residues 5–83 (Fig. 8A), where 83 is the last residue 
of the NES, from the structures of Rev (5DHV)30 and a Rev NES-Crm1 complex (3NBZ)17 using Chimera56. 
Previous studies established a hexamer of Rev on a minimal, functional 240 nucleotide RRE19. Therefore, we built 
three representative Rev hexamers using Rev 5–83 as described previously15 and aligned the NES from one Rev 
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Figure 8. Models of HIV-1 Rev 5–83 and potential interactions of Rev hexamers with a Crm1 dimer. (A) Model 
of HIV-1 Rev 5–83 built using Chimera. (B) Model of a Crm1 dimer bound to Rev NES (from33) (C) Three 
representative Rev hexamers generated using Rev 5–83 and dimerization and oligomerization surfaces (as in15). 
Rev subunits are colored from blue (subunit 1) to red (subunit 6). Different Rev NES sequences were aligned 
with one of the Crm1-bound Rev-NES peptide: NES1 from the first panel, NES6 from the second and NES 1 
from the third panel. We then observed which other Rev NES sequences were in close proximity to the second 
Crm1-bound Rev-NES peptide.
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subunit in the hexamer to a Rev-NES peptide bound to Crm1 in a model of Crm1-dimer-Rev-NES complex33 
(Fig. 8B,C). Four main aspects become apparent from these models: (1) With more structured residues of Rev 
past its second helix, only a subset of hexamers are plausible due to steric clashes of the Rev C-terminus with other 
Rev subunits, the RRE or Crm1 (Fig. 8C, left panel); (2) The RNA-bound Rev dimer, with its narrow crossing 
angle of 50° between subunits, places the two NESs in a nearly favorable configuration to associate with a Crm1 
dimer (Fig. 8C, left and right panels); (3) Different hexamer configurations can recruit Crm1 dimers using dif-
ferent combinations of Rev subunits (Fig. 8C); and (4) In some hexamer configurations, more than one NES is 
positioned close to an NES-binding groove in one of the Crm1 subunits (Fig. 8C, right panel). Given that the RRE 
enhances Rev binding to Crm133, these configurations may in fact be the dominant class of hexamers, forming an 
ensemble of nuclear export complexes wherein multiple NESs may associate with Crm1 in a variety of orienta-
tions57–59. In this way, the structuring of the ONL may restrict the possible orientations of Rev-RRE hexamers to 
a subset of export-competent configurations.
By our systematic analysis of each region of Rev, we conclude that every region of the protein influences its 
function, structure, or stability, consistent with optimal usage of limited genetic information. In the context of 
the viral genome and its overlapped reading frames, the virus is able to segregate essential functional and struc-
tural motifs and yet further tune Rev function using linker regions with relatively relaxed sequence and length 
requirements10. Indeed, recent analyses of Rev-like proteins in other retroviruses suggest that many key structural 
features - such as the key hydrophobic residues in the OD – remain conserved even as the primary sequence 
diverged60. Thus, the nuclear export function of Rev can be achieved through a wide variety of sequence configu-
rations. Furthermore, our experiments, as well as studies of patient isolates61, have demonstrated a wide range of 
Rev activity and expression levels, providing evidence of an additional levels of robustness beyond the mutational 
plasticity that governs protein stability and interactions studied in this work.
This study and others62–64 show that reporter and replication assays largely correlate, suggesting that RNA 
export activity is the major role of Rev in the viral life cycle; however it is interesting that some Rev mutants 
exhibit different behaviors. For example, Rev L75P, P76L, and ONL-9A all have lowered reporter activities (40–
60% of wild-type Rev) but are completely replication competent. Conversely, turn-8GS has export phenotype 
comparable to the above constructs but is completely defective for replication. These results illustrate that not all 
export defects lead to viral replication defects, suggesting that regulatory mechanisms may exist to compensate 
for these defects, and that reporter export activity does not always fully explain the role of Rev in the viral life 
cycle, raising the possibility that Rev may possess still unknown functions. Other roles for Rev, such as regulating 
splicing65, translation66–68 and encapsidation69–71 of RRE-containing messages have been reported as well as other 
interactions with host partners26,72–75, and many of the mutants described here may help elucidate those roles.
Future work in the endogenous HIV-1 genomic context, as well as a variety of infectable cell types may shed 
light on these questions and reveal additional evolutionary constraints that shape Rev’s robustness. Such work 
will require careful design as the kinetics of Rev expression and viral spread within an organism are complex, and 
are regulated on multiple levels. In many of these systems, selective forces do not necessarily act to produce only a 
high viral titer as they do in cell culture models. The work presented here should prove valuable in deconvoluting 
the functional consequences of mutations in these more complex systems. In sum, our results add to an increas-
ingly mature structural picture of Rev macromolecular complexes and demonstrate that large-scale mutagenesis 
approaches combined with targeted assays and structural knowledge can reveal novel and subtle mutational con-
straints in even well-studied systems.
Materials and Methods
Construction of mutants. Primers harboring the appropriate mutations were chemically synthesized 
(IDT) and then used in a 2-step PCR reaction and inserted into pcDNA4TO-2xStrep-Rev (Invitrogen mamma-
lian expression vector, described in10) via Gibson Assembly for testing in export assays. A similar strategy was 
undertaken to make viral mutants in a rev-in-nef virus as described previously10,15.
Cells and media. HEK293T cells were maintained in DMEM, high glucose (with 10% heat-inactivated fetal 
bovine serum (FBS) and 1% penicillin/streptomycin) at 37°C and 5% CO2. SupT1 cells were maintained in RPMI 
(with 25 mM HEPES pH 7.4, 10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin/streptomycin) at 
37°C and 5% CO2.
Rev reporter assays. Reporter assays to monitor Rev export activity were carried out in HEK 293 T cells 
(from ATCC) by transient transfection. In a typical experiment, 293 T cells in a 24-well plate were transfected with 
250 ng of a pCMV-GagPol-RRE reporter construct35, 25 ng of pcDNA4TO-2xStrep-Rev (Invitrogen mamma-
lian expression vector) (or indicated amount) and 10 ng pcDNA4TO-Firefly luciferase (to monitor transfection 
efficiency) using Polyjet transfection reagent (SignaGen). We chose these quantities for Rev plasmid to main-
tain accuracy in plasmid concentrations across different constructs and for easily detectable protein expression. 
Forty-eight hours after transfection, the culture supernatant was removed, the cells were lysed in Tris-buffered 
saline containing 1% Triton X-100 and protease inhibitors, and intracellular Gag (p24) was quantified by ELISA. 
Rev expression levels were verified by western blot using HRP-conjugated-anti-StrepTagII antibody (IBA bio-
sciences) with GAPDH used as a loading control. Blots were detected by chemi-luminescence using ChemiDoc 
(Biorad); exposure times were adjusted so that the signal was not saturated and bands were quantified using 
ImageJ76. Band intensities were in the linear range for these exposure conditions and for the Rev quantities used 
in our experiments (Fig. S2). For experiments with MG132, 2.5 uM proteasome inhibitor MG132 was added 
30 hours after transfection and cells were harvested 16 hours later.
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Measuring cytoplasmic gagpol mRNA levels. In order to confirm that the p24 levels quantified by 
ELISA report mainly on Rev’s nuclear export function and not because of any effects of Rev on Gag translation, 
we quantified cytoplasmic GagPol mRNA levels in the presence of some of our Rev mutants (Fig. S1). 293 T cells 
in a 24-well plate were transfected with 250 ng of a pCMV-GagPol-RRE reporter construct, 2.5 ng of pcDNA-
4TO-2xStrep-Rev (or indicated Rev mutant) and 10 ng pcDNA4TO-Firefly luciferase using Polyjet transfection 
reagent (SignaGen). as described above in Rev reporter assays. 24 hours post transfection, the culture supernatant 
was aspirated, cells were detached using DPBS containing 5 mM EDTA, washed twice in ice-cold DPBS. To lyse 
the plasma membrane, cells were resuspended gently by flicking in 175 ul of ice-cold buffer RLN (50 mM Tris.Cl 
pH 8.0, 140 mM NaCl, 1.5 mM MgCl2, 0.5% Nonidet p-40). Following a 5-minute incubation on ice, the lysate 
was centrifuged at 300xg for 2 minutes at 4°C and the supernatant (cytoplasmic extract) was used for RNA extrac-
tion using the Qiagen RNeasy kit. DNase treatment and RT-PCR reactions were set up using the BioRad iScript 
gDNA Clear cDNA synthesis kit. Relative RNA abundance was quantified by qPCR and the GagPolRRE mRNA 
levels were normalized to GAPDH mRNA levels (Fig. S1B). Primers used for qPCR were:
GagPolRRE-F: 5′ GGAAACATGGTGGACAGAGTAT 3′
GagPolRRE-R: 5′ CTGCTCCTACTATGGGTTCTTTC 3′
GAPDH-F: 5′ GTCTCCTCTGACTTCAACAGCG 3′
GAPDH-R: 5′ ACCACCCTGTTGCTGTAGCCAA 3′.
Viral replication assays. Rev mutants were cloned into the nef region of a NL4–3 proviral construct, 
mutated to ensure no expression from the endogenous rev locus15. For generation of viruses, HEK 293 T cells 
in a 6 well plate were transfected with 1000 ng of NL4–3 proviral plasmid and 20 ng of pCDNA4TO-Rev to pro-
mote robust production of viruses containing Rev mutations. Virus supernatants were collected 48 hours after 
transfection, quantified by p24 capsid ELISA and stored in aliquots at −80 °C. For viral replication assays, one 
million SupT1 cells were inoculated with 5 ng of p24 virus in 250 ul media containing 1 ug/ml PEI and 8 ug/ml 
polybrene and centrifuged for 2 hours at 37 °C. Input virus was removed, cells were washed once with 250 ul of 
PBS, resuspended in 250 ul of media and placed in an incubator at 37 °C, 5% CO215. 100 ul of virus-containing 
supernatants were collected every 48–72 hours for 20 days (and equivalent amounts of fresh media were added 
to cells) for quantification by p24 ELISA. We wish to note that the replication kinetics of an NL4–3 reference 
virus and an NL4–3 rev-in-nef virus are different, with both viruses displaying peak infection at different times 
(Fig. S1). This is likely due differences in timing and abundance of Rev-encoding messages from an endogenous 
rev locus and a rev-in-nef locus.
To monitor expression of Rev-Flag during viral replication, Rev-Flag, Rev Δ1–8-Flag and Rev 1–85-Flag 
were cloned into the nef locus of a NL4–3 proviral construct and viruses were generated as above. Three mil-
lion SupT1 cells (NIH AIDS Reagent Program) were infected with 150 ng of p24 (viral capsid) in a total vol-
ume of 6 ml containing 1 ug/ml PEI and 8 ug/ml polybrene and centrifuged for 2 hours at 37 °C at 1200xg15. 
Input virus was removed, cells were washed with 5 ml of DPBS and resuspended in 6 ml of media (RPMI sup-
plemented with 25 mM HEPES pH 7.4, 10% fetal bovine serum, 1% penicillin-streptomycin. 1.25 ml of cells 
were withdrawn on days 1–4 post infection, lysed in RIPA buffer (20 mM Tris-Cl pH 6.4, 140 mM NaCl, 1% 
NP-40, 0.5% sodium deoxycholate, 0.1% SDS), containing protease inhibitors and Flag-tagged Rev was detected 
by western blot (mouse anti-Flag antibody, Sigma) with GAPDH used as a loading control. Blots were detected 
by chemi-luminescence by exposure to an X-Ray film (>8 minute long exposures were necessary to detect Rev).
Rev mRNA stability analysis. 293 T cells in a 24-well plate were transfected as described above in Rev 
reporter assays. 18 hours post transfection, the culture supernatant was aspirated, cells were detached using DPBS 
containing 5 mM EDTA, washed twice in ice-cold DPBS and the pelleted cell volume (PCV) was measured. The 
cells were then washed once in 3x PCV of Buffer A (10 mM Tris-HCl, pH 8.0 1.5 mM MgCl2, 10 mM KCl, 0.5 mM 
DTT, 0.2U/ul Murine RNase inhibitor (New England BioLabs)) and resuspended in 5x PCV of buffer A. After 
10 minutes, Triton X-100 was added to the cells to a final concentration of 0.5%, the cells were passed through a 
25 G needle and then centrifuged at 4500 g x g, 5 minutes. The supernatant was used for RNA extraction using the 
Zymo Quick-RNA Mini Prep kit with DNase treatment. RT-PCR reactions were set up using the BioRad iScript 
Select cDNA synthesis kit using Oligo (dT) primers. RNA abundance was quantified by qPCR and the Rev mRNA 
levels were normalized to GAPDH mRNA levels. Primers used for qPCR were:
Rev-F: 5′ GACAGGCCCGAAGGAATAG 3′
Rev-R: 5′ CGCAGATCGTCCCAGATAAG 3′
GAPDH-F: 5′ GTCTCCTCTGACTTCAACAGCG 3′
GAPDH-R: 5′ ACCACCCTGTTGCTGTAGCCAA 3′.
CDMs analysis. Fitness values from previous work10, representing selection strength based on population 
genetics modeling and changes in allele frequencies during viral competition assays, were used to display the 
preferences of each amino acid at each position. To determine each position’s general hydrophobic preferences, 
we grouped these fitness values into related bins (e.g. W,F,Y) and plotted their distributions.
patient isolate analysis. Analysis of patient sequences was performed in a manner as previously 
described10. Specifically, we downloaded high-quality, curated protein alignments from the publicly available 
Los Alamos HIV Sequence Compendium (http://www.hiv.lanl.gov/) and calculated amino acid conservation 
for every position in Rev, representing 2,694 Rev sequences. Gaps not found in the reference HXB2 sequence 
were discounted from the analysis. Patient sequences consist of only viral sequences and no patient-specific 
information.
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Analysis of stop codon fitness. Data from our CDMS experiments10 were used to generate distributions 
of Rev residues 1–86 (position 86 was chosen as it is the most C-terminal position which displays selection 
against the stop codon), Rev residues 87–116, and Tat positions 66–86 (position 66 was chosen as it is the most 
N-terminal position in Tat that displays neutral or positive fitness for the stop codon). Distributions were plotted 
in R using ggplot2’s density function smoothed with a bandwidth adjustment parameter of 1 (adjust = 1).
Data Availability
Data generated and/or analyzed during the current study are available from the corresponding author on request.
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